Development and evaluation of an affordable real-time qualitative assay for determining HIV-1 virological failure in plasma and dried blood spots

Journal of Clinical Microbiology

Volumn 51, Issue 6, 2013, Pages 1899-1905

  Aitken, Susan C ^a   Kliphuis, Aletta ^b   Bronze, Michelle ^c   Wallis, Carole L ^d   Kityo, Cissy ^e   Balinda, Sheila ^e   Stevens, Wendy ^c,f   Spieker, Nicole ^b   De Oliveira, Tulio ^g   Rinke De Wit, Tobias F ^b,h   Schuurman, Rob ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b PharmAccess International   (Netherlands)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d LANCET LABORATORIES   (South Africa)

^e JOINT CLINICAL RESEARCH CENTRE   (Uganda)

^f NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^g UNIVERSITY OF KWAZULU NATAL   (South Africa)

^h AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; DRIED BLOOD SPOT TESTING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTERMETHOD COMPARISON; LIMIT OF DETECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; TANZANIA; UGANDA; VALIDATION PROCESS; VIRUS INHIBITION; VIRUS LOAD; VIRUS STRAIN;

BLOOD; DESICCATION; DRUG MONITORING; HIV INFECTIONS; HIV-1; HUMANS; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; SPECIMEN HANDLING; TANZANIA; UGANDA; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84878516947     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03305-12     Document Type: Article

References (23)

1. WHO/UNAIDS/UNICEF. 2011. Progress report 2011: global HIV/AIDS response. World Health Organization, Geneva, Switzerland. http://www.who.int/hiv/pub/ progress-report2011/en/index.html.
2. Hamers RL, Wallis CL, Kityo C, Siwale M, Mandaliya K, Conradie F, Botes ME, Wellington M, Osibogun A, Sigaloff KCE, Nankya I, Schuurman R, Wit FW, Stevens W, van Vugt M, Rinke de Wit TF. 2011. HIV-1 drug resistance among antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: multicentre observational study. Lancet Infect. Dis. 11:750-759.
3. WHO. 2012. The strategic use of antiretrovirals to help end the HIV epidemic. World Health Organization, Geneva, Switzerland. http://apps.who.int/ iris/bitstream/10665/75184/1/9789241503921-eng.pdf.
4. Sigaloff KC, Hamers RL, Wallis CL, Kityo C, Siwale M, Ive P, Botes ME, Mandaliya K, Wellington M, Osibogun A, Stevens WS, van Vugt M, de Wit TF. 2011. Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations: two arguments for viral load monitoring in Africa. J. Acquir. Immune Defic. Syndr. 58:23-31.
5. Simpson KN, Baran RW, Kirbach SE, Dietz B. 2011. Economics of switching to second-line antiretroviral therapy with lopinavir/ritonavir in Africa: estimates based on DART trial results and costs for Uganda and Kenya. Value Health 14:1048-1054.
6. WHO. 2010. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach, 2010 revision. World Health Organization, Geneva, Switzerland. http://whqlibdoc.who.int/publications/ 2010/9789241599764-eng.pdf.
7. Panel on Antiretroviral Guidelines for Adults and Adolescents. 2012. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents, p 1-239. US Department of Health and Human Services, Washington, DC. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
8. Barth RE, Aitken SC, Tempelman H, Geelen SP, van Bussel EM, Hoepelman AI, Schuurman R, Wensing AM. 2012. Accumulation of drug resistance and loss of therapeutic options precede commonly used criteria for treatment failure in HIV-1 subtype-C-infected patients. Antivir. Ther. 17:377-386.
9. Mee P, Fielding KL, Charalambous S, Churchyard GJ, Grant AD. 2008. Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa. AIDS 22:1971-1977.
10. Moore DM, Awor A, Downing R, Kaplan J, Montaner JS, Hancock J, Were W, Mermin J. 2008. CD4+ T-cell count monitoring does not accurately identify HIV-infected adults with virologic failure receiving antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 49:477-484.
11. Reynolds SJ, Nakigozi G, Newell K, Ndyanabo A, Galiwongo R, Boaz I, Quinn TC, Gray R, Wawer M, Serwadda D. 2009. Failure of immunologic criteria to appropriately identify antiretroviral treatment failure in Uganda. AIDS 23:697-700.
12. van Oosterhout JJ, Brown L, Weigel R, Kumwenda JJ, Mzinganjira D, Saukila N, Mhango B, Hartung T, Phiri S, Hosseinipour MC. 2009. Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria. Trop. Med. Int. Health 14:856-861.
13. Arredondo M, Garrido C, Parkin N, Zahonero N, Bertagnolio S, Soriano V, de Mendoza C. 2012. Comparison of HIV-1 RNA measurements obtained by using plasma and dried blood spots in the automated Abbott real-time viral load assay. J. Clin. Microbiol. 50:569-572.
14. Rottinghaus EK, Ugbena R, Diallo K, Bassey O, Azeez A, Devos J, Zhang G, Aberle-Grasse J, Nkengasong J, Yang C. 2012. Dried blood spot specimens are a suitable alternative sample type for HIV-1 viral load measurement and drug resistance genotyping in patients receiving firstline antiretroviral therapy. Clin. Infect. Dis. 54:1187-1195.
15. Muro EP, Fillekes Q, Kisanga ER, L'Homme R, Aitken SC, Mariki G, Van der Ven AJ, Dolmans W, Schuurman R, Walker AS, Gibb DM, Burger DM. 2012. Intrapartum single-dose carbamazepine reduces nevirapine levels faster and may decrease resistance after a single dose of nevirapine for perinatal HIV prevention. J. Acquir. Immune Defic. Syndr. 59:266-273.
16. Hamers RL, Oyomopito R, Kityo C, Phanuphak P, Siwale M, Sungkanuparph S, Conradie F, Kumarasamy N, Botes ME, Sirisanthana T, Abdallah S, Li PC, Ngorima N, Kantipong P, Osibogun A, Lee CK, Stevens WS, Kamarulzaman A, Derdelinckx I, Chen YM, Schuurman R, Vugt MV, Rinke de Wit TF. 2012. Cohort profile: the PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance-HIV drug resistance in sub-Saharan Africa and the Asia-Pacific. Int. J. Epidemiol. 41:43-54.
17. Drosten C, Panning M, Drexler JF, Hansel F, Pedroso C, Yeats J, de Souza Luna LK, Samuel M, Liedigk B, Lippert U, Sturmer M, Doerr HW, Brites C, Preiser W. 2006. Ultrasensitive monitoring of HIV-1 viral load by a low-cost real-time reverse transcription-PCR assay with internal control for the 5′ long terminal repeat domain. Clin. Chem. 52:1258-1266. (Pubitemid 43956016)
18. Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, McIntyre J, Lingappa JR, Celum C. 2010. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 375:2092-2098.
19. Hamers RL, Kityo C, Lange JM, Rinke de Wit TF, Mugyeni P. 2012. Global threat from drug resistant HIV in sub-Saharan Africa. BMJ 344:e4159. doi:10.1136/bmj.e4159.
20. Johannessen A, Garrido C, Zahonero N, Sandvik L, Naman E, Kivuyo SL, Kasubi MJ, Gundersen SG, Bruun JN, de Mendoza C. 2009. Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania. Clin. Infect. Dis. 49:976-981.
21. Viljoen J, Gampini S, Danaviah S, Valea D, Pillay S, Kania D, Meda N, Newell ML, Van de Perre P, Rouet F. 2010. Dried blood spot HIV-1 RNA quantification using open real-time systems in South Africa and Burkina Faso. J. Acquir. Immune Defic. Syndr. 55:290-298.
22. Kane CT, Ndiaye HD, Diallo S, Ndiaye I, Wade AS, Diaw PA, Gaye- Diallo A, Mboup S. 2008. Quantitation of HIV-1 RNA in dried blood spots by the real-time NucliSENS EasyQ HIV-1 assay in Senegal. J. Virol. Methods 148:291-295.
23. Balinda S, Ondoa P, Kliphuis A, Egau I, Bronze M, Kasambula L, Obuku EA, Schuurman R, Rinke de Wit T, Kityo C. 2012. Evaluation of a viral failure assay using dried blood spots in three clinical settings in Uganda, poster 204. First Int. Conf. Afr. Soc. Lab. Med., Cape Town, South Africa, 1 to 7 December 2012. African Society for Laboratory Medicine, Addis Ababa, Ethiopia.